about
Multidrug-resistant tuberculosis and migration to Europe.Impact on and use of an inner-city London Infectious Diseases Department by international migrants: a questionnaire survey.Engaging new migrants in infectious disease screening: a qualitative semi-structured interview study of UK migrant community health-care leadsScreening for latent TB, HIV, and hepatitis B/C in new migrants in a high prevalence area of London, UK: a cross-sectional study.Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation ChallengesCommunity acquired infections among refugees leading to Intensive Care Unit admissions in Turkey.Europe's migrants face unacceptable humanitarian situation.Charging systems for migrants in primary care: the experiences of family doctors in a high-migrant area of London.Infections in travellers returning to Turkey from the Arabian peninsula: a retrospective cross-sectional multicenter study.Evolving migrant crisis in Europe: implications for health systems.Time to rethink approaches to migrant health screening.Concerns in Turkey about infections from refugees.Tuberculosis 2013 series.UK Court decision: health care and immigration.Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.Response to Letter to the Editor by M. van der Werf, V. Hollo and C. Ködmön concerning 'Multidrug-resistant tuberculosis and migration to Europe'.How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action.Who is responsible for the vaccination of migrants in Europe?Vaccination status and needs of asylum-seeking children in Denmark: a retrospective data analysis.The role of pre-migration medical screening in high TB burden countries.New research and development strategy for tuberculosis diagnostics urgently needed.Extending migrant charging into emergency services.Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis.Migrant and refugee populations: a public health and policy perspective on a continuing global crisisForecasting the global demand for HIV monitoring and diagnostic tests: A 2016-2021 analysisGlobal health and foreign policyDivergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries, 2017National approaches to the vaccination of recently arrived migrants in Europe: A comparative policy analysis across 32 European countriesInterventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic ReviewGlobal patterns of mortality in international migrants: a systematic review and meta-analysisHealth impacts of parental migration on left-behind children and adolescents: a systematic review and meta-analysisNew guidelines launched to boost HIV testing globallyScreening migrants for tuberculosis: where next?Safeguarding health in Europe's migrant hotspotsLinkage to Care Is Important and Necessary When Identifying Infections in MigrantsAntimicrobial resistance among migrants in Europe - Authors' reply
P50
Q30244191-75C4DA4A-4A0D-42BC-9DA1-688F7BF8F2FCQ33292022-C332CC3B-4371-4A67-A985-E8B1DF3C86A5Q34343565-00B55E42-AFE1-4061-9539-EBA122FE00C6Q34669256-0C322077-DC65-47A2-BB8D-8E29D7E18AD7Q36715819-A9FF9683-6269-4772-92FC-F706FFC8ECF6Q38831958-486EA660-91BF-4C6B-8302-8951BA4B838FQ39217885-35A5EC4B-0608-4229-BE7D-DEA483E729E4Q39830243-67A76D75-D68E-4D69-B5B9-3CEACABFCA85Q39931249-C7935682-E363-4CEA-83DF-570A440E40A6Q40334620-9461A039-AE87-4A0A-8E5C-5C16EC7F04C5Q40506569-DE73CDC5-EA70-4123-9F78-EE782866E018Q40633599-3D6AD813-DB28-4E19-AA1D-6DA6F4F4603BQ42269161-F5F3CBE7-7886-4157-9A9D-A00AFF28CD8AQ43631659-44D6B68D-60B3-4069-939C-C0C7C73B9D70Q50299758-ACCD7720-278C-4DF3-A534-446CE651BEBAQ53748940-DAA92E13-C770-464D-AFDD-1C8BE7519D1AQ54205697-31BBC67A-6C4D-4774-8FEB-5DEBD0F5FBAAQ54217825-6E0E26C1-C7A8-45E0-AA25-0EEEF8C5389CQ54217856-72C122EB-848E-4F63-8AD3-FEB79A90A3CCQ54236161-4AE82032-8A75-4956-AA2A-11F2374995D0Q54259413-1673E968-20CA-4930-86DF-4D205FCB3F6EQ54299281-E2ECD6AB-6083-41FB-83BC-30C4A6973911Q54664912-D61488C7-F5FE-4B38-A3FF-6FCE7AAC3E4FQ55448019-44D5BEF1-F396-452B-90F3-B1E966D38EB3Q56888018-B673E0F8-E0E9-40E0-92BE-B1258D7219F3Q57155056-C2ED6E69-E361-4D7A-AFA5-1EAE1D6C0B03Q57180226-EF33D2EC-7750-428C-947A-B8D6DFCB4F66Q57486220-571699B9-2E56-40DC-B115-FA5167E3DE81Q58566345-478164E1-09D6-4BB6-846D-FCA2B692F7FAQ58708782-A5996752-4EBA-4CAC-8B9E-0D237C243D38Q59664710-0FCC6316-9086-4AAB-A858-9C18CDEFF97DQ60301918-22A64D7B-8202-4E2C-B16E-F33BB464A5F6Q80619909-5B430297-B1AD-4AF5-A750-EE2B6F09E7E3Q83397585-C52C6789-0D09-4D0C-9C4F-F85CDE09A23FQ88588984-2074D672-83F6-4B86-BA8C-40125936C782Q90420694-56D15FFE-8D12-4F41-B325-AD37728B6FF7Q91174669-6FAB2FDE-1313-4869-9F2B-8AAD3B86390B
P50
description
researcher ORCID ID = 0000-0003-2974-4348
@en
name
S Hargreaves
@ast
S Hargreaves
@en
S Hargreaves
@nl
type
label
S Hargreaves
@ast
S Hargreaves
@en
S Hargreaves
@nl
prefLabel
S Hargreaves
@ast
S Hargreaves
@en
S Hargreaves
@nl
P31
P496
0000-0003-2974-4348